These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 33357770

  • 1. The rodent model of impaired gastric motility induced by allyl isothiocyanate, a pungent ingredient of wasabi, to evaluate therapeutic agents for functional dyspepsia.
    Hashimoto K, Tashima K, Imai T, Matsumoto K, Horie S.
    J Pharmacol Sci; 2021 Jan; 145(1):122-129. PubMed ID: 33357770
    [Abstract] [Full Text] [Related]

  • 2. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride.
    Matsunaga Y, Tanaka T, Yoshinaga K, Ueki S, Hori Y, Eta R, Kawabata Y, Yoshii K, Yoshida K, Matsumura T, Furuta S, Takei M, Tack J, Itoh Z.
    J Pharmacol Exp Ther; 2011 Mar; 336(3):791-800. PubMed ID: 21123674
    [Abstract] [Full Text] [Related]

  • 3. Acotiamide Hydrochloride, a Therapeutic Agent for Functional Dyspepsia, Enhances Acetylcholine-induced Contraction via Inhibition of Acetylcholinesterase Activity in Circular Muscle Strips of Guinea Pig Stomach.
    Ito K, Kawachi M, Matsunaga Y, Hori Y, Ozaki T, Nagahama K, Hirayama M, Kawabata Y, Shiraishi Y, Takei M, Tanaka T.
    Drug Res (Stuttg); 2016 Apr; 66(4):196-202. PubMed ID: 26418413
    [Abstract] [Full Text] [Related]

  • 4. Effects of mosapride citrate, a 5-HT4-receptor agonist, on gastric distension-induced visceromotor response in conscious rats.
    Seto Y, Yoshida N, Kaneko H.
    J Pharmacol Sci; 2011 Apr; 116(1):47-53. PubMed ID: 21521930
    [Abstract] [Full Text] [Related]

  • 5. Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs.
    Nagahama K, Matsunaga Y, Kawachi M, Ito K, Tanaka T, Hori Y, Oka H, Takei M.
    Neurogastroenterol Motil; 2012 Jun; 24(6):566-74, e256. PubMed ID: 22429221
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacological and clinical profile of acotiamide hydrochloride hydrate (Acofide(®) Tablets 100 mg), a novel therapeutic agent for functional dyspepsia (FD)].
    Matsunaga Y, Tanaka T, Saito Y, Kato H, Takei M.
    Nihon Yakurigaku Zasshi; 2014 Feb; 143(2):84-94. PubMed ID: 24531902
    [No Abstract] [Full Text] [Related]

  • 7. Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting acetylcholinesterase activity in rats.
    Kawachi M, Matsunaga Y, Tanaka T, Hori Y, Ito K, Nagahama K, Ozaki T, Inoue N, Toda R, Yoshii K, Hirayama M, Kawabata Y, Takei M.
    Eur J Pharmacol; 2011 Sep; 666(1-3):218-25. PubMed ID: 21651906
    [Abstract] [Full Text] [Related]

  • 8. Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia.
    Amarapurkar DN, Rane P.
    J Indian Med Assoc; 2004 Dec; 102(12):735-7, 760. PubMed ID: 15871365
    [Abstract] [Full Text] [Related]

  • 9. Effects of Acotiamide on the Esophageal Motility Function in Patients with Esophageal Motility Disorders: A Pilot Study.
    Muta K, Ihara E, Fukaura K, Tsuchida O, Ochiai T, Nakamura K.
    Digestion; 2016 Dec; 94(1):9-16. PubMed ID: 27326454
    [Abstract] [Full Text] [Related]

  • 10. A double-blind placebo controlled study of acotiamide hydrochloride for efficacy on gastrointestinal motility of patients with functional dyspepsia.
    Nakamura K, Tomita T, Oshima T, Asano H, Yamasaki T, Okugawa T, Kondo T, Kono T, Tozawa K, Ohda Y, Fukui H, Kazuhito F, Hirota S, Watari J, Miwa H.
    J Gastroenterol; 2017 May; 52(5):602-610. PubMed ID: 27639387
    [Abstract] [Full Text] [Related]

  • 11. Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study.
    Sun J, Yuan YZ, Holtmann G.
    Clin Drug Investig; 2011 Dec 01; 31(12):865-75. PubMed ID: 22035464
    [Abstract] [Full Text] [Related]

  • 12. Validation of 13C-acetic acid breath test by measuring effects of loperamide, morphine, mosapride, and itopride on gastric emptying in mice.
    Matsumoto K, Kimura H, Tashima K, Uchida M, Horie S.
    Biol Pharm Bull; 2008 Oct 01; 31(10):1917-22. PubMed ID: 18827355
    [Abstract] [Full Text] [Related]

  • 13. Acotiamide affects antral motility, but has no effect on fundic motility, gastric emptying or symptom perception in healthy participants.
    Masuy I, Tack J, Verbeke K, Carbone F.
    Neurogastroenterol Motil; 2019 Apr 01; 31(4):e13540. PubMed ID: 30663175
    [Abstract] [Full Text] [Related]

  • 14. Electrogastrography associated with symptomatic changes after prokinetic drug treatment for functional dyspepsia.
    Lim HC, Lee SI, Chen JD, Park H.
    World J Gastroenterol; 2012 Nov 07; 18(41):5948-56. PubMed ID: 23139612
    [Abstract] [Full Text] [Related]

  • 15. Improvement of meal-related symptoms and epigastric pain in patients with functional dyspepsia treated with acotiamide was associated with acylated ghrelin levels in Japan.
    Yamawaki H, Futagami S, Kawagoe T, Maruki Y, Hashimoto S, Nagoya H, Sato H, Kodaka Y, Gudis K, Akamizu T, Sakamoto C, Iwakiri K.
    Neurogastroenterol Motil; 2016 Jul 07; 28(7):1037-47. PubMed ID: 26920949
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of new gastro-intestinal prokinetic (ENGIP-II) study.
    Walwaikar PP, Kulkarni SS, Bargaje RS.
    J Indian Med Assoc; 2005 Dec 07; 103(12):708-9. PubMed ID: 16821670
    [Abstract] [Full Text] [Related]

  • 17. Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis.
    Yang YJ, Bang CS, Baik GH, Park TY, Shin SP, Suk KT, Kim DJ.
    BMC Gastroenterol; 2017 Jun 26; 17(1):83. PubMed ID: 28651565
    [Abstract] [Full Text] [Related]

  • 18. Prokinetic effect of the 5-HT4R agonist mosapride on canine gastric motility.
    Tsukamoto A, Ohno K, Maeda S, Nakashima K, Fukushima K, Fujino Y, Tsujimoto H.
    J Vet Med Sci; 2011 Dec 26; 73(12):1635-7. PubMed ID: 21785238
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography.
    Kusunoki H, Haruma K, Manabe N, Imamura H, Kamada T, Shiotani A, Hata J, Sugioka H, Saito Y, Kato H, Tack J.
    Neurogastroenterol Motil; 2012 Jun 26; 24(6):540-5, e250-1. PubMed ID: 22385472
    [Abstract] [Full Text] [Related]

  • 20. [Use of itopride in the symptoms of functional dyspepsia in Russia: results of a phase IV prospective open-label multicenter clinical trial].
    Kas'ianenko VI, Denisov NL, Vasil'ev IuV.
    Ter Arkh; 2014 Jun 26; 86(8):35-41. PubMed ID: 25306742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.